E

Evotec SE

D
EVO
USD
0.42
(10.9375%)
Market Closed
4,121.00
Volume
-0.492
EPS
-
Div Yield
-8.218782
P/E
1,512,754,831.68
Market Cap
Today
10.9375%
1 Week
10.078%
1 Month
28.313%
6 Months
-17.442%
12 Months
-51.034%
Year To Date
-63.714%
All Time
0%

Title:
Evotec SE

Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000employees and 18 production sites mainly in Europe and the United States.
Do you need help or have a question?